My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 101

    1.

    Angiotensins and Alzheimer's disease: a bench to bedside overview.

    Kehoe PG.

    Alzheimers Res Ther. 2009 Jul 9;1(1):3.PMID: 19674436 [PubMed]Related articlesFree article

    2.

    Basal forebrain cholinergic dysfunction in Alzheimer's disease--interrelationship with beta-amyloid, inflammation and neurotrophin signaling.

    Schliebs R.

    Neurochem Res. 2005 Jun-Jul;30(6-7):895-908. Review.PMID: 16187224 [PubMed - indexed for MEDLINE]Related articles

    3.

    Can the controversy of the role of aluminum in Alzheimer's disease be resolved? What are the suggested approaches to this controversy and methodological issues to be considered?

    Savory J, Exley C, Forbes WF, Huang Y, Joshi JG, Kruck T, McLachlan DR, Wakayama I.

    J Toxicol Environ Health. 1996 Aug 30;48(6):615-35. Review.PMID: 8772802 [PubMed - indexed for MEDLINE]Related articles

    4.

    Links between the pathology of Alzheimer's disease and vascular dementia.

    Sadowski M, Pankiewicz J, Scholtzova H, Li YS, Quartermain D, Duff K, Wisniewski T.

    Neurochem Res. 2004 Jun;29(6):1257-66.PMID: 15176482 [PubMed - indexed for MEDLINE]Related articles

    5.

    Alzheimer's disease pathogenesis and therapeutic interventions.

    Parihar MS, Hemnani T.

    J Clin Neurosci. 2004 Jun;11(5):456-67. Review.PMID: 15177383 [PubMed - indexed for MEDLINE]Related articles

    6.

    Rationale for the development of cholinesterase inhibitors as anti-Alzheimer agents.

    Lahiri DK, Rogers JT, Greig NH, Sambamurti K.

    Curr Pharm Des. 2004;10(25):3111-9. Review.PMID: 15544501 [PubMed - indexed for MEDLINE]Related articles

    7.

    Alzheimer's disease and inflammation: a review of cellular and therapeutic mechanisms.

    Halliday G, Robinson SR, Shepherd C, Kril J.

    Clin Exp Pharmacol Physiol. 2000 Jan-Feb;27(1-2):1-8. Review.PMID: 10696521 [PubMed - indexed for MEDLINE]Related articles

    8.

    Interactions between the amyloid and cholinergic mechanisms in Alzheimer's disease.

    Pákáski M, Kálmán J.

    Neurochem Int. 2008 Nov;53(5):103-11. Epub 2008 Jun 17. Review.PMID: 18602955 [PubMed - indexed for MEDLINE]Related articles

    9.

    Immunological approaches for amyloid-beta clearance toward treatment for Alzheimer's disease.

    Solomon B.

    Rejuvenation Res. 2008 Apr;11(2):349-57. Review.PMID: 18341423 [PubMed - indexed for MEDLINE]Related articles

    10.

    Amyloid-induced neurofibrillary tangle formation in Alzheimer's disease: insight from transgenic mouse and tissue-culture models.

    Götz J, Schild A, Hoerndli F, Pennanen L.

    Int J Dev Neurosci. 2004 Nov;22(7):453-65. Review.PMID: 15465275 [PubMed - indexed for MEDLINE]Related articles

    11.

    Influence of the apolipoprotein E genotype on amyloid deposition and neurofibrillary tangle formation in Alzheimer's disease.

    Nagy Z, Esiri MM, Jobst KA, Johnston C, Litchfield S, Sim E, Smith AD.

    Neuroscience. 1995 Dec;69(3):757-61.PMID: 8596645 [PubMed - indexed for MEDLINE]Related articles

    12.

    Accumulated amyloid-beta peptide and hyperphosphorylated tau protein: relationship and links in Alzheimer's disease.

    Huang HC, Jiang ZF.

    J Alzheimers Dis. 2009 Jan;16(1):15-27. Review.PMID: 19158417 [PubMed - indexed for MEDLINE]Related articles

    13.

    [Therapy of Alzheimer disease]

    Kovács T.

    Neuropsychopharmacol Hung. 2009 Mar;11(1):27-33. Review. Hungarian. PMID: 19731816 [PubMed - indexed for MEDLINE]Related articles

    15.

    TGF-beta1 Pathway as a New Target for Neuroprotection in Alzheimer's Disease.

    Caraci F, Battaglia G, Bruno V, Bosco P, Carbonaro V, Giuffrida ML, Drago F, Sortino MA, Nicoletti F, Copani A.

    CNS Neurosci Ther. 2009 Nov 19. [Epub ahead of print]PMID: 19925479 [PubMed - as supplied by publisher]Related articles

    16.

    Magnetic resonance imaging of Alzheimer's pathology in the brains of living transgenic mice: a new tool in Alzheimer's disease research.

    Jack CR Jr, Marjanska M, Wengenack TM, Reyes DA, Curran GL, Lin J, Preboske GM, Poduslo JF, Garwood M.

    Neuroscientist. 2007 Feb;13(1):38-48. Review.PMID: 17229974 [PubMed - indexed for MEDLINE]Related articles

    17.

    [Cholesterol and Alzheimer's disease]

    Kálmán J, Janka Z.

    Orv Hetil. 2005 Sep 11;146(37):1903-11. Review. Hungarian. PMID: 16255374 [PubMed - indexed for MEDLINE]Related articles

    18.

    Caspases as therapeutic targets in Alzheimer's disease: is it time to "cut" to the chase?

    Rohn TT, Head E.

    Int J Clin Exp Pathol. 2009;2(2):108-18. Epub 2008 Jun 10.PMID: 19079646 [PubMed]Related articlesFree article

    19.

    Molecular characterization and measurement of Alzheimer's disease pathology: implications for genetic and environmental aetiology.

    Wischik CM, Harrington CR, Mukaetova-Ladinska EB, Novak M, Edwards PC, McArthur FK.

    Ciba Found Symp. 1992;169:268-93; discussion 293-302. Review.PMID: 1490426 [PubMed - indexed for MEDLINE]Related articles

    20.

    Vaccination as a therapeutic approach to Alzheimer's disease.

    Wisniewski T, Boutajangout A.

    Mt Sinai J Med. 2010 Jan;77(1):17-31.PMID: 20101719 [PubMed - in process]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Write to the Help Desk